Marilena Vrana: ”Plasma Powers Possibility” Continues to Resonate Far Beyond an Awareness Week
Marilena Vrana, Vice President at the Plasma Protein Therapeutics Association (PPTA) Europe, shared on LinkedIn:
”With October now behind us, the IPAW 2025 theme “Plasma Powers Possibility” continues to resonate far beyond an awareness week.
While International Plasma Awareness Week may officially only span the course of a week, its message endures all year long.
Every plasma donation fuels possibility, hope, and opportunity for patients.
Committed, healthy donors are the generous start of a promising future for patients across Europe.
Their generous act of giving allows patients to live healthier, fuller lives.
As patients’ need for plasma-derived medicines continues to grow, we must work together to build resilient systems that support donors and strengthen access for those people whose lives depend on them.
I invite you to read my reflections and share your own on how we can build on the IPAW momentum and continue raising awareness year-round.
Read the full blog post here.”
Stay updated with Hemostasis Today.
-
Nov 5, 2025, 04:08Omid Seidizadeh: Pleased to Announce the Establishment of EAHAD Working Group on VWD
-
Nov 5, 2025, 03:54Marilena Vrana: ''Plasma Powers Possibility'' Continues to Resonate Far Beyond an Awareness Week
-
Nov 5, 2025, 03:30Dirk Sibbing on The Importance of ISAR-REACT 5 trial and 2020 ESC Guidelines for ACS
-
Nov 5, 2025, 03:14Abrham Mulugeta Shares Insights on Tranexamic Acid: Exploring the WHO WOMAN Trial
-
Nov 5, 2025, 03:01Shivanand Kumatagi Delivered Session on ISBT 128 at KMC Manipal
-
Nov 4, 2025, 08:57Toluwalase Awoyemi: Digital Health Meets Maternal Heart Care
-
Nov 4, 2025, 08:53Rebecca Ahrens Nicklas Shares FDA Interactions on Interventional Genetics with The Rare Disease Community
-
Nov 3, 2025, 09:13Claudio Carrubba on How Timing Truly Matters in Trauma Embolization
-
Nov 3, 2025, 08:57Multiplex Apolipoprotein Panel Boosts Cardiovascular Risk Prediction and Precision Therapy
-
Nov 3, 2025, 08:46Rachel Lamerton and Colleagues on Activation of Platelets in Flow Cytometry
-
Nov 4, 2025, 09:10OCCUPI Trial Analysis Highlights Benefits of OCT Guidance in ACS Patients
-
Oct 29, 2025, 07:31The Use of Artificial Intelligence to Improve Detection of Acute Incidental Pulmonary Emboli - JTH
-
Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
-
Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
-
Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
-
Nov 4, 2025, 09:17HaemophiliaIRL Series Begins․ Advances in von Willebrand Disease Treatment
-
Nov 4, 2025, 09:14Exploring Molecular Pathways of Aging in Hematopoiesis․ FEBS Workshop 2025
-
Nov 4, 2025, 08:28Fritz Roth Thanks Supporters of Science Magazine Study Linking Genes to High Cholesterol and Heart Attack Risk
-
Nov 4, 2025, 08:22Colleen Silk on Novo Nordisk Taking the 2025 Prix Galien US Award
-
Nov 4, 2025, 08:14Cristina Anton: Excited to Be Part of Women in Hematology!